<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30148">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02714231</url>
  </required_header>
  <id_info>
    <org_study_id>DS-HB-LP</org_study_id>
    <nct_id>NCT02714231</nct_id>
  </id_info>
  <brief_title>Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion</brief_title>
  <official_title>A Randomized Controlled Trial of 3 Different Methods for Pain Relief During Intrauterine Device Insertion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to compare the analgesic effect of oral diclofenac sodium versus
      oral hyoscine butyl bromide versus cervical lidocaine-prilocaine cream during intrauterine
      device insertion.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean pain score during insertion</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score</measure>
    <time_frame>5 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Family Planning</condition>
  <arm_group>
    <arm_group_label>diclofenac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral diclofuhenac sodium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hyoscine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral hyoscine butyl bromide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lidocaine_prilocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cervical lidocaine-prilocaine cream</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diclofenac sodium (cataflam)</intervention_name>
    <description>The patients in the study group will take one tablet of cataflam 50 mg 30 min before the scheduled time of the procedure</description>
    <arm_group_label>diclofenac</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hyoscine butyl bromide (buscopan)</intervention_name>
    <description>The patients in the study group will take one tablet of buscopan 10 mg 30 min before the scheduled time of the procedure</description>
    <arm_group_label>hyoscine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine-prilocaine cream</intervention_name>
    <description>The patients in the study group before tenaculum placement, a syringe filled with 3 ml of prilocaine cream will be applied to the ectocervix at the planned tenaculum site (1 ml), followed by 2 ml will be placed in the cervix up to the level of the internal os then we will wait 3 minutes before intrauterine device insertion</description>
    <arm_group_label>lidocaine_prilocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women not taken analgesics or anxiolytics in the 24 hours prior insertion

          -  Women not taken misoprostol prior to intrauterine device insertion

          -  No contraindication to or history of allergic reaction to lidocaine

          -  Women who will accept to participate in the study

        Exclusion Criteria:

          -  Any contraindication to intrauterine device placement
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ahmed abbas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Woman health hospital Assiut</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ahmed Abbas</name>
      <address>
        <city>Assiut</city>
        <state>Cairo</state>
        <zip>002</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 12, 2017</lastchanged_date>
  <firstreceived_date>March 14, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Abbas</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>EMLA</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Butylscopolammonium Bromide</mesh_term>
    <mesh_term>Scopolamine Hydrobromide</mesh_term>
    <mesh_term>Bromides</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
